In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Company's Code of Conduct for Prevention of Insider Trading and clarification issued by BSE vide its circular dated April 2, 2019 bearing no. LIST/COMP/01/2019-20, Kwality Pharmaceuticals has informed that the Trading Window for dealing in the Securities of the Company shall remain closed for all the Board of Directors, Designated Persons and their immediate relatives, with effect from Friday April 01st 2022 till 48 hour after declaration of the Audited Financial Results for the half year and year ended on March 31, 2022. The date of announcement of the Audited Financial Results for the Year ended 31st March, 2022 shall be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1862.15 |
| Dr. Reddys Labs. | 1350.00 |
| Cipla | 1440.30 |
| Zydus Lifesciences | 1101.50 |
| Lupin | 2342.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: